Why the study?
How do sublingual nitroglycerin and intravenous propranolol affect right ventricular fiber shortening and hemodynamics in patients with and without coronary artery disease?
Population
Patients with and without coronary artery disease (normal and arteriosclerotic subjects)
Design
Other
Authors
Loading...
May guide acute therapy selection in CAD; leaves open validation of metabolic effects in prospective studies.
How do sublingual nitroglycerin and intravenous propranolol affect right ventricular fiber shortening and hemodynamics in patients with and without coronary artery disease?
Nitroglycerin and propranolol have distinct and sometimes opposing acute hemodynamic and metabolic effects on the myocardium in patients with and without coronary artery disease.
Robin et al. (1967) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: